Diego Arruda Falcão
Research Subjects
Diego Arruda Falcão has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Aderson da Silva Araújo
Department of Internal Medicine Hematology and Hemotherapy Foundation of Pernambuco Recife Pernambuco Brazil
2 shared publications - Andreia Soares da Silva
Universidade de Pernambuco
2 shared publications - Antonio Roberto Lucena Araujo
Department of Genetics, Federal University of Pernambuco, Recife, Brazil
2 shared publications - Betânia Lucena Domingues Hatzlhofer
Federal University of Pernambuco, Brazil
2 shared publications - Gabriela Silva Arcanjo
Genetics Postgraduate Program Federal University of Pernambuco Recife Pernambuco Brazil
2 shared publications - Isabela Cristina Cordeiro Farias
Universidade de Pernambuco
2 shared publications
Latest Publications
- Open Access
Genomic Insights into the Spread of Vaccinia Virus Strain Cantagalo to Rural Regions of Northeastern Brazil
Vaccinia virus strain Cantagalo (CTGV) causes a pustular disease in dairy cows and milkers in Brazil. Outbreaks in several states have been frequently reported, but the full genome sequence and genomic analysis of isolates from the Northeast region have never been described. Here, we report CTGV outbreaks in two Northeastern states, affecting milkers, lactating cows, and suckling calves. The farms were located in the main dairy belt of Pernambuco, in the Borborema Plateau, and in a rural region of Bahia. Of the 12 samples that tested positive for CTGV, five had their genomes fully sequenced. They cluster with CTGV isolates from Goiás (Midwest region, 2022) and São Paulo (Southeast region, 2023) but diverge from isolates from the Southeast in the early 2000s. Two clinical isolates have accumulated greater genetic variability and segregate separately from the other three isolates from the Northeast, showing evidence of potential recombination events with the FAI-01 isolate from the Midwest region (2022). We also detected Parapoxvirus and CTGV coinfection in some animals. These findings likely suggest different episodes of virus introduction in these states. The spread of CTGV raises concerns about the potential impact on local economic activities and underscores the importance of avoiding raw milk consumption.
Open AccessGenomic Insights into the Spread of Vaccinia Virus Strain Cantagalo to Rural Regions of Northeastern Brazil
Vaccinia virus strain Cantagalo (CTGV) causes a pustular disease in dairy cows and milkers in Brazil. Outbreaks in several states have been frequently reported, but the full genome sequence and genomic analysis of isolates from the Northeast region have never been described. Here, we report CTGV outbreaks in two Northeastern states, affecting milkers, lactating cows, and suckling calves. The farms were located in the main dairy belt of Pernambuco, in the Borborema Plateau, and in a rural region of Bahia. Of the 12 samples that tested positive for CTGV, five had their genomes fully sequenced. They cluster with CTGV isolates from Goiás (Midwest region, 2022) and São Paulo (Southeast region, 2023) but diverge from isolates from the Southeast in the early 2000s. Two clinical isolates have accumulated greater genetic variability and segregate separately from the other three isolates from the Northeast, showing evidence of potential recombination events with the FAI-01 isolate from the Midwest region (2022). We also detected Parapoxvirus and CTGV coinfection in some animals. These findings likely suggest different episodes of virus introduction in these states. The spread of CTGV raises concerns about the potential impact on local economic activities and underscores the importance of avoiding raw milk consumption.
- Open Access
Case Series of Adverse Pregnancy Outcomes Associated with Oropouche Virus Infection
The Oropouche virus (OROV) is an arbovirus (Peribunyaviridae: Orthobunyavirus) that traditionally causes febrile outbreaks in Latin America’s Amazon region. Previously, OROV was not associated with severe pregnancy outcomes. During the 2022–2024 outbreak in Brazil, OROV expanded geographically, revealing links to adverse pregnancy outcomes. This study describes six cases with varied fetal outcomes, including miscarriage, antepartum, intrauterine fetal demise (IFD), and normal development, correlating with maternal symptoms but not symptom severity. Vertical transmission was confirmed by detecting OROV through RT-qPCR, ELISA, and immunohistochemistry in fetal tissues. Genome sequencing from an IFD case identified a novel reassortment pattern reported in the 2022–2024 outbreak. Severe encephalomalacia, meningoencephalitis, vascular compromise, and multi-organ damage were evident, underscoring the significant risk OROV poses to fetal development and emphasizing the need for further investigation.
Open AccessCase Series of Adverse Pregnancy Outcomes Associated with Oropouche Virus Infection
The Oropouche virus (OROV) is an arbovirus (Peribunyaviridae: Orthobunyavirus) that traditionally causes febrile outbreaks in Latin America’s Amazon region. Previously, OROV was not associated with severe pregnancy outcomes. During the 2022–2024 outbreak in Brazil, OROV expanded geographically, revealing links to adverse pregnancy outcomes. This study describes six cases with varied fetal outcomes, including miscarriage, antepartum, intrauterine fetal demise (IFD), and normal development, correlating with maternal symptoms but not symptom severity. Vertical transmission was confirmed by detecting OROV through RT-qPCR, ELISA, and immunohistochemistry in fetal tissues. Genome sequencing from an IFD case identified a novel reassortment pattern reported in the 2022–2024 outbreak. Severe encephalomalacia, meningoencephalitis, vascular compromise, and multi-organ damage were evident, underscoring the significant risk OROV poses to fetal development and emphasizing the need for further investigation.
- Open Access
- 7 August 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (9) , e442997314
LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia
Objective: This study aimed to evaluate whether the single nucleotide polymorphisms (SNPs) +191 C>A (rs4644) and +292 A>C (rs4652) of the LGALS3 gene and the serum levels of galectin-3 (gal-3) are associated with clinical events in patients with sickle cell anemia (SCA). Methods: SNP +191 and +292 of the LGALS3 gene were detected by the TaqMan PCR system in real time. Gal-3 levels were measured in serum by ELISA. The study included 322 patients, mean age 36 (21-84). Results: AA and CA genotypes of the +191 region were related to lower levels of gal-3 when compared to CC genotype (p=0.0296). Lower level of gal-3 was also associated with the +191/+292 (AA/CC; CA/CC) diplotypes (p=0.0137) compared to the diplotypes (CC/AA; CC/CC; CC/AC; CA/AC). There was no association between serum levels of galectin-3 and genotype frequencies of the LGALS3 +191 and +292 polymorphisms with clinical events in SCA. Conclusion: The polymorphisms +191 and +292 of the LGALS3 are associated to decrease in serum levels of gal-3. However, no association of polymorphisms and levels of gal-3 with clinical events was observed in patients SCA.
- 7 August 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (9) , e442997314
Open AccessLGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia
Objective: This study aimed to evaluate whether the single nucleotide polymorphisms (SNPs) +191 C>A (rs4644) and +292 A>C (rs4652) of the LGALS3 gene and the serum levels of galectin-3 (gal-3) are associated with clinical events in patients with sickle cell anemia (SCA). Methods: SNP +191 and +292 of the LGALS3 gene were detected by the TaqMan PCR system in real time. Gal-3 levels were measured in serum by ELISA. The study included 322 patients, mean age 36 (21-84). Results: AA and CA genotypes of the +191 region were related to lower levels of gal-3 when compared to CC genotype (p=0.0296). Lower level of gal-3 was also associated with the +191/+292 (AA/CC; CA/CC) diplotypes (p=0.0137) compared to the diplotypes (CC/AA; CC/CC; CC/AC; CA/AC). There was no association between serum levels of galectin-3 and genotype frequencies of the LGALS3 +191 and +292 polymorphisms with clinical events in SCA. Conclusion: The polymorphisms +191 and +292 of the LGALS3 are associated to decrease in serum levels of gal-3. However, no association of polymorphisms and levels of gal-3 with clinical events was observed in patients SCA.
- Open Access
- 23 April 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (7) , e439974240
MBL2 gene polymorphisms are not related to the occurrence of cerebrovascular disease in sickle cell anemia
Objective: This study has as objective to verify whether MBL2 gene polymorphisms are related to the occurrence of cerebrovascular disease (CD) in sickle cell anemia (SCA) patients. Methods: Overall, 259 unrelated SCA patients were enrolled. The patients were divided into three groups: control group, stroke group ad range of risk group. Peripheral blood samples were collected and DNA extraction was performed. All patients were genotyped for exon 1, promoter region -221 and promoter region -550 of MBL2 gene, along with β-globin gene haplotypes. Results: Concerning the genotyping of the MBL2, there was no difference in the frequency of allelic and genotypic variants of the exon 1 and the promoter regions -221 and -550 of the MBL2 gene among the studied groups. Conclusion: Despite the small number of patients, and the lack of association between MBL2 polymorphisms and CD, our study represents an effort to understand the impact of MBL2 polymorphisms in the clinical outcome of patients with SCA.
- 23 April 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (7) , e439974240
Open AccessMBL2 gene polymorphisms are not related to the occurrence of cerebrovascular disease in sickle cell anemia
Objective: This study has as objective to verify whether MBL2 gene polymorphisms are related to the occurrence of cerebrovascular disease (CD) in sickle cell anemia (SCA) patients. Methods: Overall, 259 unrelated SCA patients were enrolled. The patients were divided into three groups: control group, stroke group ad range of risk group. Peripheral blood samples were collected and DNA extraction was performed. All patients were genotyped for exon 1, promoter region -221 and promoter region -550 of MBL2 gene, along with β-globin gene haplotypes. Results: Concerning the genotyping of the MBL2, there was no difference in the frequency of allelic and genotypic variants of the exon 1 and the promoter regions -221 and -550 of the MBL2 gene among the studied groups. Conclusion: Despite the small number of patients, and the lack of association between MBL2 polymorphisms and CD, our study represents an effort to understand the impact of MBL2 polymorphisms in the clinical outcome of patients with SCA.